Clinical Trial

Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS

Unknown Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 28, 2024 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
multi-center, prospective, randomized, open-label phase III
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT01917552
Lead Sponsor Asan Medical Center
Collaborators: Ulsan University Hospital, Seoul National University Bundang Hospital, Gangnam Severance Hospital, Seoul National University Boramae Hospital, Ajou University School of Medicine, Chung-Ang University Hospital, Hallym University Medical Center, Inje University Haeundae Paik Hospital, Kyung Hee University Hospital, Gachon University Gil Medical Center, Kangbuk Samsung Hospital, Kyungpook National University Hospital
Conditions Gastric Cancer
Enrollment 870 participants
Start Date 2013-08-19
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2024-02-28